Sponsored • Webinar
Upcoming Virtual Events
Join virtual conferences and connect with industry leaders worldwide. Discover upcoming events, access credible insights, and expand your professional network—all from home.
Pharma & Biotech
Symeres Strengthens US Foothold with Exemplify Buy
Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens Symeres’ foothold in the US, where it already generates about 50% of its revenues.
Facing Strong Headwinds
So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.
Expansions in High-Potency API Manufacturing
DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.
Understanding the Requirements of Safe HPAPI Manufacturing
The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable targets for oncology and other areas.
The Rise of HPAPI Molecules
For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.
Why CDMOs Should Consider Value-Based Pricing
Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.
